Rockefeller Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Rockefeller Capital Management's BIIB Position: Q3 2026 in Review
Rockefeller Capital Management increased its Biogen (BIIB) stake by 189% in Q3 2026, buying an estimated $2.45M and bringing the position to 17,687 shares worth $4M. The position accounts for 0.01% of the portfolio, ranked #1099.
Rockefeller Capital Management first reported a position in BIIB in Q1 2018 and has held it in 27 quarters since. The position peaked at $114M in Q3 2018. 899 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Rockefeller Capital Management held 17,687 shares of Biogen worth $4M as of Q3 2026.
- Rockefeller Capital Management bought 11,559 Biogen shares in Q3 2026, an estimated $2.45M.
- Biogen made up 0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1099 holding.
- Rockefeller Capital Management first reported a position in Biogen in Q1 2018 and has held it in 27 quarters since.
- Rockefeller Capital Management's Biogen position peaked at $114M in Q3 2018.
- 899 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.